Currently, most of the recommendations for genetic testing for non-BRCA1/2 genes are based on specific cancer syndromes with well-studied clinical features, such as the Li-Fraumeni syndrome and Cowden syndrome. The gene discussed is BRCA1; the disease is cancer.